Fundz
Real-time · AI · Cross-signal

Antheia, Inc. just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Antheia, Inc., plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Antheia Secures Second Project Agreement with the BioMaP-Consortium Valued at up to $12M

Dec 03, 2024•over 1 year ago

Contract Type

agreement

Menlo ParkInformation Technology

Description

Antheia announced a new government project agreement funded by the Department of Health and Human Services' (HHS) Defense Production Act (DPA) Title III Program, valued at $12 million over a two-year period. The agreement aims to accelerate domestic biomanufacturing of critical pharmaceutical ingredients and mitigate drug shortages.

Company Information

Company

Antheia, Inc.

Location

1505 O'BRIEN DRIVE, SUITE B1

Menlo Park, California, United States

About

Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines. Antheia’s team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Antheia, Inc.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.